Pyxis Oncology, Inc
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase 1/2 Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid Tumors (NCT06795412) | Pyxis Oncology, Inc | 2025-04-15 |
| Study of PYX-106 in Solid Tumors (NCT05718557) | Pyxis Oncology, Inc | 2023-05-23 |
| A Study of PYX-201 in Advanced Solid Tumors (NCT05720117) | Pyxis Oncology, Inc | 2023-03-14 |
Track Pyxis Oncology, Inc automatically
Every clearance here is in the API, with alerts when new ones post.